TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer

See also
Status	Clinical Trial	Phase
Completed	`NCT01860898` - A Phase I Study of iPS Cell Generation From Patients With COPD	N/A
Completed	`NCT00046787` - Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer	Phase 2
Recruiting	`NCT03212404` - Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers	Phase 1
Recruiting	`NCT03554473` - M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers	Phase 1/Phase 2
Terminated	`NCT00094978` - Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum	Phase 1
Recruiting	`NCT04162041` - Topotecan Plus M6620 (VX-970) vs. Topotecan Alone in People With Relapsed Small-Cell Lung Cancer	Phase 2
Completed	`NCT03092739` - A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens
Completed	`NCT00305942` - Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer	Phase 2
Terminated	`NCT00324558` - Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)	Phase 2
Completed	`NCT00359359` - A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer	Phase 1/Phase 2
Completed	`NCT00191750` - A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned	Phase 2
Recruiting	`NCT05461430` - Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Recruiting	`NCT02366741` - Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study	N/A
Active, not recruiting	`NCT01900951` - Temozolomide as Maintenance Therapy in Small Cell Lung Cancer	Phase 2
Completed	`NCT00826644` - Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient	Phase 3
Completed	`NCT00284154` - Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer	Phase 2
Recruiting	`NCT00100256` - Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy	Phase 1/Phase 2
Completed	`NCT00126828` - Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer	Phase 1/Phase 2
Terminated	`NCT02034123` - Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma	Phase 1
Recruiting	`NCT05500391` - Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring	Phase 2

NCT number	NCT02608411
Study type	Interventional
Source	Istituto Oncologico Veneto IRCCS
Contact
Status	Terminated
Phase	Phase 2
Start date	February 19, 2016
Completion date	February 21, 2017

TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) — TIMES

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms